Accordingly, in MAFLD, these mechanisms can promote the increase of liver injuries from simple to NASH and even further to cirrhosis; this is characterized by rises in liver enzymes (AST, ALT, GGT) that function as markers of the injury [69]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.